In this study, we used negatively isolated human basophils together with patient information and a lupus-prone mouse model to demonstrate that activated basophils amplify autoantibody and IL-17 production, thereby contributing to the pathogenesis of SLE. Here, IL17A is linked to systemic lupus erythematosus.